ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
RP561
|
12K |
6.3M |
1 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
12K
|
6.3M
|
1
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
RP561
|
12K |
6.3M |
19 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
12K
|
6.3M
|
19
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Macquarie Australia Conference - Presentation
|
|
RP561
|
48 |
18K |
1 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
48
|
18K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Katelin’s Turn is HERE!!!
|
|
RP561
|
260 |
148K |
1 |
17/09/23 |
17/09/23 |
ASX - By Stock
|
260
|
148K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Medium term milestones
|
|
RP561
|
89 |
47K |
8 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
89
|
47K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Medium term milestones
|
|
RP561
|
89 |
47K |
5 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
89
|
47K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Medium term milestones
|
|
RP561
|
89 |
47K |
12 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
89
|
47K
|
12
|
|
ASX - By Stock
|
CKA |
Re:
Ann: First Revenue from Coal Sales Approaching
|
|
RP561
|
366 |
119K |
4 |
21/08/23 |
21/08/23 |
ASX - By Stock
|
366
|
119K
|
4
|
|
ASX - By Stock
|
PNV |
Re:
Short Activity in PNV
|
|
RP561
|
6.8K |
2.1M |
0 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
6.8K
|
2.1M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
RP561
|
1.3K |
729K |
29 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
1.3K
|
729K
|
29
|
|
ASX - By Stock
|
PNV |
Re:
Ann: First ever A$7M Sales Month
|
|
RP561
|
126 |
48K |
0 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
126
|
48K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: First ever A$7M Sales Month
|
|
RP561
|
126 |
48K |
2 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
126
|
48K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Moonsoon Briefing Thurs 20 April
|
|
RP561
|
94 |
42K |
7 |
22/04/23 |
22/04/23 |
ASX - By Stock
|
94
|
42K
|
7
|
|
ASX - By Stock
|
PNV |
Re:
Ann: PolyNovo enters India market
|
|
RP561
|
321 |
95K |
13 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
321
|
95K
|
13
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Change of Director's Interest Notice - David Williams
|
|
RP561
|
33 |
14K |
4 |
09/05/22 |
09/05/22 |
ASX - By Stock
|
33
|
14K
|
4
|
|
ASX - By Stock
|
PNV |
Re:
Ann: 1H FY22 Results Presentation
|
|
RP561
|
508 |
116K |
0 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
508
|
116K
|
0
|
|
ASX - By Stock
|
ADO |
Re:
Ann: AnteoTech raises $8.0m in strongly supported SPP
|
|
RP561
|
241 |
82K |
4 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
241
|
82K
|
4
|
|
ASX - By Stock
|
BRN |
Re:
Ann: OTCQX Exchange Upgrade and Ticker
|
|
RP561
|
228 |
82K |
39 |
16/04/21 |
16/04/21 |
ASX - By Stock
|
228
|
82K
|
39
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
RP561
|
12K |
6.3M |
3 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
12K
|
6.3M
|
3
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
RP561
|
19K |
11M |
0 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
19K
|
11M
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
RP561
|
19K |
11M |
0 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
19K
|
11M
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Taiwan FDA Approval for PolyNovo
|
|
RP561
|
51 |
17K |
2 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
51
|
17K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
RP561
|
12K |
6.3M |
5 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
12K
|
6.3M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Updated Broker Report: Bel Potter
|
|
RP561
|
165 |
80K |
2 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
165
|
80K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
RP561
|
12K |
6.3M |
2 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
12K
|
6.3M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RP561
|
18K |
7.0M |
3 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
18K
|
7.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
RP561
|
18K |
7.0M |
4 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
18K
|
7.0M
|
4
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
RP561
|
19K |
11M |
4 |
22/06/20 |
22/06/20 |
ASX - By Stock
|
19K
|
11M
|
4
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
RP561
|
19K |
11M |
5 |
20/06/20 |
20/06/20 |
ASX - By Stock
|
19K
|
11M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
RP561
|
1.0K |
499K |
0 |
20/05/20 |
20/05/20 |
ASX - By Stock
|
1.0K
|
499K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
RP561
|
3.2K |
1.4M |
1 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
3.2K
|
1.4M
|
1
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Trading Update
|
|
RP561
|
140 |
58K |
0 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
140
|
58K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: PolyNovo presents at Macquarie - presentation slides
|
|
RP561
|
59 |
28K |
1 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
59
|
28K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Trading Update
|
|
RP561
|
140 |
58K |
0 |
19/04/20 |
19/04/20 |
ASX - By Stock
|
140
|
58K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Debt Finance Facility
|
|
RP561
|
10 |
5.3K |
5 |
07/04/20 |
07/04/20 |
ASX - By Stock
|
10
|
5.3K
|
5
|
|
ASX - By Stock
|
PNV |
Re:
30th June 2020 Share Price Prediction
|
|
RP561
|
270 |
144K |
2 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
270
|
144K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Broker upgrade
|
|
RP561
|
92 |
105K |
5 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
92
|
105K
|
5
|
|
ASX - By Stock
|
PNV |
Re:
Broker upgrade
|
|
RP561
|
92 |
105K |
7 |
02/02/20 |
02/02/20 |
ASX - By Stock
|
92
|
105K
|
7
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
RP561
|
19K |
11M |
2 |
27/01/20 |
27/01/20 |
ASX - By Stock
|
19K
|
11M
|
2
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
RP561
|
19K |
11M |
1 |
22/01/20 |
22/01/20 |
ASX - By Stock
|
19K
|
11M
|
1
|
|
ASX - By Stock
|
PNV |
Re:
Do you really understand what a 510k approval with the FDA means?
|
|
RP561
|
57 |
28K |
1 |
16/01/20 |
16/01/20 |
ASX - By Stock
|
57
|
28K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Two Million Dollar Month
|
|
RP561
|
253 |
161K |
7 |
10/01/20 |
10/01/20 |
ASX - By Stock
|
253
|
161K
|
7
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Two Million Dollar Month
|
|
RP561
|
253 |
161K |
2 |
10/01/20 |
10/01/20 |
ASX - By Stock
|
253
|
161K
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Ann: AGM 2019 Chairman, CEO & SVP Sales Address
|
|
RP561
|
144 |
98K |
5 |
17/11/19 |
17/11/19 |
ASX - By Stock
|
144
|
98K
|
5
|
|
ASX - By Stock
|
PNV |
Re:
Ann: AGM 2019 Chairman, CEO & SVP Sales Address
|
|
RP561
|
144 |
98K |
0 |
16/11/19 |
16/11/19 |
ASX - By Stock
|
144
|
98K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: PolyNovo presents in New York
|
|
RP561
|
36 |
21K |
7 |
27/10/19 |
27/10/19 |
ASX - By Stock
|
36
|
21K
|
7
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
RP561
|
12K |
6.3M |
1 |
13/10/19 |
13/10/19 |
ASX - By Stock
|
12K
|
6.3M
|
1
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Annual Report FY19 and 4E
|
|
RP561
|
43 |
28K |
1 |
22/08/19 |
22/08/19 |
ASX - By Stock
|
43
|
28K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
RP561
|
3.2K |
1.4M |
5 |
30/07/19 |
30/07/19 |
ASX - By Stock
|
3.2K
|
1.4M
|
5
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
RP561
|
3.2K |
1.4M |
6 |
30/07/19 |
30/07/19 |
ASX - By Stock
|
3.2K
|
1.4M
|
6
|
|